Ergoteles’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,631
Closed -$1.95M 184
2023
Q2
$1.95M Buy
+20,631
New +$1.99M 0.09% 280
2023
Q1
Sell
-263,433
Closed -$24.1M 1323
2022
Q4
$24.1M Buy
263,433
+232,118
+741% +$22.1M 0.89% 14
2022
Q3
$3.02M Sell
31,315
-2,675
-8% -$287K 0.11% 192
2022
Q2
$3.45M Buy
33,990
+23,017
+210% +$2.4M 0.1% 203
2022
Q1
$1.18M Buy
10,973
+6,967
+174% +$708K 0.04% 380
2021
Q4
$431K Sell
4,006
-1,954
-33% -$190K 0.02% 698
2021
Q3
$519K Buy
5,960
+3,651
+158% +$330K 0.02% 567
2021
Q2
$216K Sell
2,309
-11,992
-84% -$1.17M ﹤0.01% 1235
2021
Q1
$1.36M Buy
+14,301
New +$1.34M 0.04% 328
2020
Q4
Sell
-2,800
Closed -$286K 709
2020
Q3
$286K Buy
+2,800
New +$263K 0.04% 360

Other funds holding CHRW

Ergoteles's CHRW Position: Q3 2023 in Review

Ergoteles sold out of C.H. Robinson (CHRW) in Q3 2023, closing a stake of 20,631 shares — an estimated $1.95M sold.

Ergoteles first reported a position in CHRW in Q3 2020 and held it in 10 quarters. The position peaked at $24.1M in Q4 2022. 602 funds tracked by Wall St. Rank hold CHRW as of Q3 2023.

  • Ergoteles reported no remaining C.H. Robinson position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 20,631 C.H. Robinson shares in Q3 2023, an estimated $1.95M.
  • Ergoteles first reported a position in C.H. Robinson in Q3 2020 and held it in 10 quarters.
  • Ergoteles's C.H. Robinson position peaked at $24.1M in Q4 2022.
  • 602 funds tracked by Wall St. Rank held C.H. Robinson as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.